Robert Iannone - 05 Mar 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Signature
By: /s/Adam Guttmann, as attorney in fact For: Robert Iannone
Issuer symbol
JAZZ
Transactions as of
05 Mar 2025
Net transactions value
-$1,709,257
Form type
4
Filing time
07 Mar 2025, 18:49:14 UTC
Previous filing
03 Mar 2025
Next filing
12 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Disposed to Issuer $727,959 -5,239 -5.6% $138.95 89,104 05 Mar 2025 Direct F1
transaction JAZZ Ordinary Shares Sale $764,578 -5,532 -6.2% $138.21 83,572 07 Mar 2025 Direct F2, F3
transaction JAZZ Ordinary Shares Sale $216,720 -1,548 -1.9% $140.00 82,024 07 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
F2 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $138.19 to $138.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.